COMMUNIQUÉS West-GlobeNewswire

Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
01/02/2018
LOS ANGELES, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced [...]
Wildflower Closes on $2 Million Private Placement to Meet Massive California Demand
01/02/2018
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the " Company ") is pleased to announce a private placement of units (“ Units ”) at a price of C$1.50 per Unit for [...]
Shire plc : Notice of Results
01/02/2018
Shire to announce full year 2017 results Dublin, Ireland - February 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce full year 2017 earnings on Wednesday February 14, 2018. Results press release will be [...]
Nuvectra™ Announces Pricing of Follow-On Stock Offering
01/02/2018
PLANO, Texas, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 [...]
Predictive Technology Group, Inc. (PRED) Appoints Ronald Barhorst to Chair Its Financial Advisory Board
01/02/2018
SALT LAKE CITY, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
01/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Abattis Enters Into Definitive Agreement to Acquire 49% Stake In CannaNUMUS Blockchain
01/02/2018
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into an investment agreement (the “ [...]
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas
01/02/2018
Data Demonstrate AFM13 in Combination with Keytruda® (Pembrolizumab) Doubled Complete Response Rate in Hodgkin Lymphoma Patients Early Data Suggest New Opportunity for AFM13 in CD30-positive Lymphoma AFM13 is Clinically [...]
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
01/02/2018
2017 revenue of $159.2 million, an increase of 96 percent from 2016 Fourth quarter revenue of $53.3 million, an increase of 124 percent from fourth quarter 2016 Cash and marketable securities at December 31, 2017 of $ [...]
Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening
01/02/2018
BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than 1000 people screened [...]
Assure Holdings to Present at the 2018 World Outlook Financial Conference
01/02/2018
PARKER, Colo., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSX-V: IOM ) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, will be participating in the 2018 [...]
Devonian Announces Acquisition of Altius Healthcare
01/02/2018
Transaction highlights: Provide Devonian sales and marketing bench strength Create a compelling financial and operational platform for future growth QUÉBEC CITY, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group [...]
Devonian annonce l’acquisition de Altius Healthcare
01/02/2018
Faits saillants de la transaction: Procure des capacités de vente et de marketing à Devonian Création d’une plate-forme opérationnelle et financière probante pour la croissance future QUÉBEC, 01 févr. 2018 (GLOBE [...]
Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhibitor at 10th Annual T-Cell Lymphoma Forum
01/02/2018
BURLINGAME, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Diffusion Pharmaceuticals Announces Allowances of Two U.S. Patent Applications
01/02/2018
CHARLOTTESVILLE, Va., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies
01/02/2018
GAITHERSBURG, Md., Feb. 01, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it has introduced a Research Use Only (RUO) Acuitas® AMR Gene Panel u5.47 test for commercial sale. The Acuitas AMR [...]
Shire plc : Total voting rights
01/02/2018
Total Voting Rights February 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]
Celtaxsys announces the issue of four new patents expanding its pipeline of selective leukotriene B4 modulation anti-inflammatory medicines
01/02/2018
New patents build on previously granted composition of matter protection for acebilustat, with additional intellectual protection for use in cystic fibrosis, as well as new compositions for second generation anti- [...]

Pages